1. Home
  2. BNR vs PIII Comparison

BNR vs PIII Comparison

Compare BNR & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$11.64

Market Cap

126.5M

Sector

Health Care

ML Signal

N/A

Logo P3 Health Partners Inc.

PIII

P3 Health Partners Inc.

N/A

Current Price

$8.08

Market Cap

33.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
PIII
Founded
2014
2015
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.5M
33.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BNR
PIII
Price
$11.64
$8.08
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
46.7K
18.2K
Earning Date
06-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,459,080,000.00
Revenue This Year
$111.65
$7.67
Revenue Next Year
N/A
$2.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$1.52
52 Week High
$41.72
$16.89

Technical Indicators

Market Signals
Indicator
BNR
PIII
Relative Strength Index (RSI) 57.68 31.90
Support Level $8.91 $2.39
Resistance Level $12.89 $11.55
Average True Range (ATR) 1.12 0.48
MACD 0.19 -0.13
Stochastic Oscillator 61.56 0.41

Price Performance

Historical Comparison
BNR
PIII

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.

Share on Social Networks: